Manchester Capital Management LLC purchased a new stake in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 6,909 shares of the company's stock, valued at approximately $123,000.
Other large investors also recently bought and sold shares of the company. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in Grail in the 4th quarter worth about $244,000. Moloney Securities Asset Management LLC purchased a new position in shares of Grail during the 4th quarter valued at approximately $559,000. Wesbanco Bank Inc. acquired a new stake in Grail in the 4th quarter valued at $523,000. Slow Capital Inc. purchased a new stake in Grail in the 4th quarter worth $2,379,000. Finally, abrdn plc purchased a new position in Grail during the fourth quarter valued at $3,768,000.
Grail Stock Performance
GRAL traded up $5.47 on Wednesday, reaching $52.60. 2,026,113 shares of the company's stock were exchanged, compared to its average volume of 1,456,898. Grail, Inc. has a twelve month low of $12.33 and a twelve month high of $63.99. The stock's fifty day moving average price is $24.61 and its 200-day moving average price is $18.40.
Analyst Ratings Changes
Several research firms recently weighed in on GRAL. Wolfe Research started coverage on shares of Grail in a research report on Friday, November 15th. They set a "peer perform" rating for the company. Morgan Stanley began coverage on Grail in a research report on Wednesday, November 27th. They issued an "equal weight" rating and a $16.00 target price on the stock.
Check Out Our Latest Report on Grail
About Grail
(
Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Featured Articles
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
